Why Side Effects Matter When Choosing Your Treatment
Wegovy Side Effects vs Mounjaro: UK Stock Availability Advantage
Understanding the side effect differences between Wegovy and Mounjaro becomes crucial when both treatments are readily available in the UK. Wegovy's single GLP-1 receptor targeting typically produces predictable gastrointestinal effects, while Mounjaro's dual GIP and GLP-1 mechanism may offer different tolerability patterns for some patients. At EverydayMeds, we maintain comprehensive stock levels of both treatments, allowing your prescriber to switch between options if side effects become problematic. This flexibility is only possible with reliable UK supply chains that many pharmacies struggle to maintain.
The advantage of having both Wegovy side effects vs Mounjaro options in stock means no treatment delays if your initial prescription needs adjustment. Our GPhC-registered pharmacy (#9012878) processes over 500 weight management prescriptions weekly, giving us insight into real-world tolerability patterns. While clinical trials show similar gastrointestinal side effect rates, individual responses vary significantly, making stock availability essential for personalised care.
Pricing Comparison: Wegovy vs Mounjaro Treatment Costs
Wegovy pricing starts at £79.99 for the 0.25mg starter dose, progressing to £94.99 for 0.5mg, £99.99 for 1mg, £139.99 for 1.7mg, and £209.99 for the 2.4mg maintenance dose. Our Getting Started bundles offer convenience, with the Intro Duo (0.25mg & 0.5mg) at £169.99 and Progress Duo (0.5mg & 1mg) at £189.99. New customers apply discount code FIRST40 at checkout, while returning patients use DOSE25 to access these final prices. The gradual dose escalation protocol means most patients require all five strengths over their first 16 weeks of treatment.
When comparing Wegovy side effects vs Mounjaro costs, both treatments require similar financial commitment for effective weight management. Our 3-pen Ultimate Stability Trio provides three months of 2.4mg maintenance supply for £649.99, ensuring uninterrupted treatment once you reach your optimal dose. This pricing structure reflects the prescription-only medicine status and specialised cold-chain storage requirements that maintain product efficacy throughout the UK supply network.
Clinical Evidence: Side Effect Profiles in STEP vs SURMOUNT Trials
The STEP trial programme, particularly Wilding et al., NEJM, 2021, demonstrated that Wegovy's most common side effects include nausea (44% vs 9% placebo), diarrhoea (30% vs 9%), and vomiting (24% vs 3%). These gastrointestinal effects typically diminish as patients progress through the dose escalation protocol. Most participants who experienced side effects found them manageable with dietary adjustments and proper injection timing.
Mounjaro's SURMOUNT trials showed comparable gastrointestinal side effect patterns, though the dual incretin mechanism may influence individual tolerability. When evaluating Wegovy side effects vs Mounjaro profiles, both treatments demonstrated similar discontinuation rates due to adverse events. The key difference lies in the receptor targeting mechanisms rather than overall side effect frequency, making personalised prescriber guidance essential for treatment selection.
How Wegovy Works: GLP-1 Mechanism and Side Effect Origins
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural incretin hormones to regulate appetite and blood sugar levels. This mechanism works primarily in the brain's appetite centres and digestive system, slowing gastric emptying and promoting satiety after smaller meals. The delayed stomach emptying explains why nausea and digestive side effects are most common during the initial weeks of treatment. Understanding this mechanism helps patients anticipate and manage potential side effects more effectively. As your body adjusts to the medication over the 16-week dose escalation period, these effects typically become less pronounced, allowing the appetite regulation benefits to predominate.
UK Ordering Process: From Assessment to Cold-Chain Delivery
Our streamlined process begins with a 3-minute online clinical assessment covering your medical history, current medications, and weight management goals. Qualified prescribers review applications within 72 hours (or 24 hours with express service) to determine suitability for either treatment option. Once approved, your chosen Wegovy or Mounjaro prescription ships via temperature-controlled next-day delivery across the UK. This cold-chain logistics system maintains the 2-8°C storage requirements from our GPhC-registered facility directly to your door. The entire process typically completes within 4-5 working days, ensuring you can begin treatment promptly while comparing how Wegovy side effects vs Mounjaro tolerability affects your daily routine.
Storage and Practical Considerations: Temperature Stability Differences
Wegovy offers superior storage flexibility compared to Mounjaro, remaining stable at room temperature (below 30°C) for up to 6 weeks once removed from refrigeration, while Mounjaro maintains stability for only 21 days. This three-week advantage makes Wegovy more suitable for frequent travellers or those with limited refrigerator space. Both treatments use pre-filled injection pens, but Wegovy's FlexTouch design provides dose flexibility during the escalation phase. The 16-week dose escalation protocol requires five different pen strengths, making reliable supply chains essential for uninterrupted treatment. Understanding these practical differences helps inform the Wegovy side effects vs Mounjaro decision beyond clinical considerations alone.
Side Effect Management Strategies: UK-Specific Guidance
Managing Wegovy side effects vs Mounjaro requires understanding each treatment's unique characteristics within the UK healthcare context. Wegovy's single-receptor targeting typically produces more predictable side effect patterns, making it easier for UK prescribers to provide specific management advice. The most effective strategy involves taking injections at consistent times, preferably before your smallest meal of the day, to minimise gastric disruption. Staying well-hydrated and avoiding high-fat meals during the initial weeks significantly reduces nausea intensity.
When Wegovy side effects vs Mounjaro become problematic, having both treatments in stock allows rapid prescription switching without treatment gaps. Our clinical team provides UK-specific dietary guidance cards with each shipment, including NHS-approved meal timing strategies. This comprehensive support approach, combined with reliable stock availability, ensures patients can optimise their chosen treatment while maintaining consistent progress towards their weight management goals.
Expert Prescription Assessment: Choose Your Optimal Treatment
Ready to start your weight management journey with professional medical oversight? Our qualified prescribers assess both Wegovy and Mounjaro suitability during your clinical consultation, considering your medical history, lifestyle factors, and side effect concerns. Use discount code FIRST40 (new customers) or DOSE25 (returning patients) at checkout to access our competitive pricing structure. With comprehensive stock levels maintained year-round, you'll never face treatment delays regardless of which prescription-only medicine your prescriber recommends. Visit https://everydaymeds.co.uk/collections/wegovy to begin your confidential assessment today, knowing that expert guidance and reliable supply await your decision. Both treatments must be used alongside a reduced-calorie diet and increased physical activity for optimal results.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
